• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双氢青蒿素通过活性氧到P53再到β-连环蛋白信号通路抑制胶质瘤侵袭性。

Dihydroartemisin inhibits glioma invasiveness via a ROS to P53 to β-catenin signaling.

作者信息

Que Zhongyou, Wang Ping, Hu Yi, Xue Yixue, Liu Xiaobai, Qu Chengbin, Ma Jun, Liu Yunhui

机构信息

Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang 110004, People's Republic of China; Liaoning Research Center for Translational Medicine in Nervous System Disease, Shenyang 110004, People's Republic of China.

Department of Neurobiology, College of Basic Medicine, China Medical University, Shenyang 110122, People's Republic of China.

出版信息

Pharmacol Res. 2017 May;119:72-88. doi: 10.1016/j.phrs.2017.01.014. Epub 2017 Jan 19.

DOI:10.1016/j.phrs.2017.01.014
PMID:28111262
Abstract

Dihydroartemisinin(DHA) is the active metabolic derivative of artemisinin. DHA has potential therapeutic effects on glioma but the detailed mechanism is unclear. In this study, we investigated the role and the underlying mechanisms of DHA in its inhibition of glioma cells. U87 cells are wild-type p53 glioblastoma cells and U251 cells contain mutant p53. DHA inhibited the proliferation, migration and invasion of glioma cells in a dose-dependent manner. DHA promoted reactive oxygen species production and activated p53 in two glioma cell lines, U87 and U251. In U87 cells, DHA significantly up-regulated the expression of p-β-catenin (S45) and inhibited EGFR, β-catenin, p-β-catenin (Y333) and matrix metalloprotease7/9 activity. In U251 cells, DHA significantly up-regulated p-β-catenin (S45), p-β-catenin (Y333) and EGFR, but the expression of β-cateninwas unchanged. We also found that DHA and sh-β-catenin prevented the proliferation of U87 and U251 cells in vivo. In conclusion, DHA inhibited the migration and invasion of human glioma cells with different types of p53 via different pathways.

摘要

双氢青蒿素(DHA)是青蒿素的活性代谢衍生物。DHA对胶质瘤具有潜在治疗作用,但其具体机制尚不清楚。在本研究中,我们探究了DHA在抑制胶质瘤细胞中的作用及其潜在机制。U87细胞是野生型p53胶质母细胞瘤细胞,U251细胞含有突变型p53。DHA以剂量依赖方式抑制胶质瘤细胞的增殖、迁移和侵袭。DHA在两种胶质瘤细胞系U87和U251中促进活性氧生成并激活p53。在U87细胞中,DHA显著上调p-β-连环蛋白(S45)的表达,并抑制表皮生长因子受体(EGFR)、β-连环蛋白、p-β-连环蛋白(Y333)和基质金属蛋白酶7/9的活性。在U251细胞中, DHA显著上调p-β-连环蛋白(S45)、p-β-连环蛋白(Y333)和EGFR,但β-连环蛋白的表达未改变。我们还发现,DHA和β-连环蛋白短发夹RNA(sh-β-catenin)在体内可抑制U87和U251细胞的增殖。总之,DHA通过不同途径抑制不同p53类型的人胶质瘤细胞的迁移和侵袭。

相似文献

1
Dihydroartemisin inhibits glioma invasiveness via a ROS to P53 to β-catenin signaling.双氢青蒿素通过活性氧到P53再到β-连环蛋白信号通路抑制胶质瘤侵袭性。
Pharmacol Res. 2017 May;119:72-88. doi: 10.1016/j.phrs.2017.01.014. Epub 2017 Jan 19.
2
Dihydroartemisinin inhibits tumor growth of human osteosarcoma cells by suppressing Wnt/β-catenin signaling.二氢青蒿素通过抑制 Wnt/β-连环蛋白信号通路抑制人骨肉瘤细胞的生长。
Oncol Rep. 2013 Oct;30(4):1723-30. doi: 10.3892/or.2013.2658. Epub 2013 Aug 5.
3
Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine.紫草素通过靶向磷酸化β-连环蛋白和磷酸化PI3K/Akt抑制人胶质母细胞瘤细胞的迁移和侵袭:一种传统中药抗胶质瘤疗效的潜在机制。
Int J Mol Sci. 2015 Oct 9;16(10):23823-48. doi: 10.3390/ijms161023823.
4
Dihydroartemisinin suppresses glioma proliferation and invasion via inhibition of the ADAM17 pathway.双氢青蒿素通过抑制ADAM17通路抑制胶质瘤的增殖和侵袭。
Neurol Sci. 2015 Mar;36(3):435-40. doi: 10.1007/s10072-014-1963-6. Epub 2014 Oct 10.
5
Fucoxanthin Activates Apoptosis via Inhibition of PI3K/Akt/mTOR Pathway and Suppresses Invasion and Migration by Restriction of p38-MMP-2/9 Pathway in Human Glioblastoma Cells.岩藻黄质通过抑制PI3K/Akt/mTOR通路激活细胞凋亡,并通过限制p38-MMP-2/9通路抑制人胶质母细胞瘤细胞的侵袭和迁移。
Neurochem Res. 2016 Oct;41(10):2728-2751. doi: 10.1007/s11064-016-1989-7. Epub 2016 Jul 9.
6
Dihydroartemisinin prompts amplification of photodynamic therapy-induced reactive oxygen species to exhaust Na/H exchanger 1-mediated glioma cells invasion and migration.双氢青蒿素促使光动力治疗诱导的活性氧扩增,以耗尽 Na/H 交换器 1 介导的神经胶质瘤细胞侵袭和迁移。
J Photochem Photobiol B. 2021 Jun;219:112192. doi: 10.1016/j.jphotobiol.2021.112192. Epub 2021 Apr 17.
7
Dihydroartemisinin inhibits the tumorigenesis and invasion of gastric cancer by regulating STAT1/KDR/MMP9 and P53/BCL2L1/CASP3/7 pathways.双氢青蒿素通过调控 STAT1/KDR/MMP9 和 P53/BCL2L1/CASP3/7 通路抑制胃癌的发生发展和侵袭转移。
Pathol Res Pract. 2021 Feb;218:153318. doi: 10.1016/j.prp.2020.153318. Epub 2020 Dec 13.
8
Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of glioma cells by inactivating Wnt/β-catenin signaling.二烯丙基三硫抑制胶质瘤细胞的增殖、侵袭和血管生成,作用机制为阻断 Wnt/β-连环蛋白信号通路。
Cell Tissue Res. 2017 Dec;370(3):379-390. doi: 10.1007/s00441-017-2678-9. Epub 2017 Aug 17.
9
Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/β-catenin signaling.青蒿素及其衍生物可通过Wnt/β-连环蛋白信号通路显著抑制肺肿瘤发生和肿瘤转移。
Oncotarget. 2016 May 24;7(21):31413-28. doi: 10.18632/oncotarget.8920.
10
Wnt/β-catenin pathway involvement in ionizing radiation-induced invasion of U87 glioblastoma cells.Wnt/β-连环蛋白信号通路参与电离辐射诱导的U87胶质母细胞瘤细胞侵袭
Strahlenther Onkol. 2015 Aug;191(8):672-80. doi: 10.1007/s00066-015-0858-7. Epub 2015 Jun 14.

引用本文的文献

1
Molecular Mechanisms of Extract in Breast Cancer: Targeting EGFR/TP53 and PI3K-AKT-mTOR Signaling via ROS-Mediated Apoptosis.提取物在乳腺癌中的分子机制:通过活性氧介导的细胞凋亡靶向表皮生长因子受体/TP53和磷脂酰肌醇-3激酶-蛋白激酶B-哺乳动物雷帕霉素靶蛋白信号通路
Curr Issues Mol Biol. 2025 Jul 14;47(7):546. doi: 10.3390/cimb47070546.
2
Sesquiterpene Lactones as Promising Anti-Glioblastoma Drug Candidates Exerting Complex Effects on Glioblastoma Cell Viability and Proneural-Mesenchymal Transition.倍半萜内酯作为有前景的抗胶质母细胞瘤候选药物,对胶质母细胞瘤细胞活力和神经前体-间充质转化产生复杂影响。
Biomedicines. 2025 Jan 8;13(1):133. doi: 10.3390/biomedicines13010133.
3
Dysregulation of Iron Homeostasis Mediated by FTH Increases Ferroptosis Sensitivity in TP53-Mutant Glioblastoma.
由FTH介导的铁稳态失调增加了TP53突变型胶质母细胞瘤对铁死亡的敏感性。
Neurosci Bull. 2025 Apr;41(4):569-582. doi: 10.1007/s12264-024-01322-y. Epub 2024 Dec 12.
4
Glutamine Metabolism Heterogeneity in Glioblastoma Unveils an Innovative Combination Therapy Strategy.胶质母细胞瘤中谷氨酰胺代谢异质性揭示了一种创新的联合治疗策略。
J Mol Neurosci. 2024 May 10;74(2):52. doi: 10.1007/s12031-024-02201-x.
5
TUG1/MAZ/FTH1 Axis Attenuates the Antiglioma Effect of Dihydroartemisinin by Inhibiting Ferroptosis.TUG1/MAZ/FTH1 轴通过抑制铁死亡来减弱二氢青蒿素的抗胶质瘤作用。
Oxid Med Cell Longev. 2022 Sep 17;2022:7843863. doi: 10.1155/2022/7843863. eCollection 2022.
6
Development of nanoscale drug delivery systems of dihydroartemisinin for cancer therapy: A review.双氢青蒿素用于癌症治疗的纳米级药物递送系统的研究进展:综述
Asian J Pharm Sci. 2022 Jul;17(4):475-490. doi: 10.1016/j.ajps.2022.04.005. Epub 2022 May 14.
7
Anoikis resistance in diffuse glioma: The potential therapeutic targets in the future.弥漫性胶质瘤中的失巢凋亡抗性:未来潜在的治疗靶点。
Front Oncol. 2022 Aug 15;12:976557. doi: 10.3389/fonc.2022.976557. eCollection 2022.
8
Promotion of Ros-mediated Bax/Cyt-c apoptosis by polyphyllin II leads to suppress growth and aggression of glioma cells.重楼皂苷II通过促进Ros介导的Bax/细胞色素c凋亡从而抑制胶质瘤细胞的生长和侵袭。
Transl Cancer Res. 2021 Sep;10(9):3894-3905. doi: 10.21037/tcr-21-966.
9
Dihydroartemisinin: A Potential Drug for the Treatment of Malignancies and Inflammatory Diseases.双氢青蒿素:一种治疗恶性肿瘤和炎症性疾病的潜在药物。
Front Oncol. 2021 Oct 7;11:722331. doi: 10.3389/fonc.2021.722331. eCollection 2021.
10
Ligand-modified homologous targeted cancer cell membrane biomimetic nanostructured lipid carriers for glioma therapy.配体修饰的同源靶向癌细胞膜仿生纳米结构脂质载体用于脑胶质瘤治疗。
Drug Deliv. 2021 Dec;28(1):2241-2255. doi: 10.1080/10717544.2021.1992038.